@elonmusk - for the price of the UK HS2 Rail link the UK government could buy 3.1 Million Cybercabs (pre discount) free transport for the people of the UK and you would get your bonus!
Biosimilars are expanding access to affordable biologic therapies for chronic conditions, with the WHO leading efforts to strengthen regulatory frameworks and global partnerships to improve their availability and quality. Learn more here: https://t.co/Jsjzpt1WBx
In a recent Life Science Leader podcast, Dr. Jim Doherty, Ph.D., from Acumen Pharmaceuticals, discusses challenges in Alzheimer's treatment, the role of biomarkers, and the latest advancements in CNS drug development. Listen here: https://t.co/QT9Ha2t7bv
Why is 3.5% the magic number for biotech funding? The biotech sector has faced turbulence in recent years due to rising rates and market uncertainty. Experts say once interest rates hit 3.5%, capital costs drop, sparking investor interest and reviving IPOs.
Today we're releasing the structures of over 600M metagenomic proteins—the least understood proteins on earth. A view into the dark matter of the protein universe.
Explore the ESM Metagenomic Atlas here: https://t.co/wXmP0x1HlH